Paras Biopharmaceuticals Finland Oy
Is this your company? Claim this profile
Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
Paras Biopharmaceuticals Finland Oy is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Finland
Founded:2004
Employees:1,199
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval A8767H
FDA · #APR-P48JICNF · 2022-11-01
Drug Approval N17HGO
PMDA · #APR-MIDFUHBL · 2020-07-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-FHMCN1YB
Issued: 2020-05-26
Expires: 2025-02-19
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-9PC5LE74
Issued: 2020-06-12
Expires: 2025-06-03
Loading CDMO intelligence...
Key facts about Paras Biopharmaceuticals Finland Oy
- Paras Biopharmaceuticals Finland Oy is headquartered in Finland.
- Paras Biopharmaceuticals Finland Oy was founded in 2004.
- Paras Biopharmaceuticals Finland Oy has 1,199 employees.
- Paras Biopharmaceuticals Finland Oy's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Paras Biopharmaceuticals Finland Oy
Directory pages this company appears in, each with the full list of matching manufacturers.